J&J Fined $4.5M Over False Drug Promotions

Law360, New York (March 2, 2009, 12:00 AM EST) -- A West Virginia judge has ordered Johnson & Johnson to pay $4.475 million in civil penalties for allegedly giving doctors in the state misleading information about the anti-psychotic drug Risperdal and the narcotic pain patch Duragesic.

Judge Martin J. Gaughan of The Circuit Court of Brooke County, West Virginia last week ordered J&J and subsidiary Janssen Pharmaceutica Inc. to pay a reduced fine for 4,450 allegedly false or misleading statements they made about the drugs in brochures, phone calls and letters to physicians in the state....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.